JMSB vs JNJ · P/E 13, rev $113.3M vs P/E 17, rev $49.37B
John Marshall Bancorp Inc (JMSB) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
John Marshall Bancorp Inc (JMSB) is a banks - regional company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported JMSB revenue for 2025-12-31 was $113.3M. Net income was $21.2M. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JMSB currently screens at market cap $300.6M and trailing P/E 13.5.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
JMSB currently screens at market cap $300.6M and trailing P/E 13.5. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the JMSB and JNJ stock pages for the full models.
Not investment advice.